Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2022) 209 (7): 1227–1228.

LETTERS TO THE EDITOR

J Immunol (2022) 209 (7): 1229–1233.

PILLARS OF IMMUNOLOGY

J Immunol (2022) 209 (7): 1235–1236.

This Pillars of Immunology article is a commentary on “Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro,” a pivotal article written by T.M. Schmitt and J.C. Zúñiga-Pflücker, and published in Immunity, in 2002.

CUTTING EDGE

J Immunol (2022) 209 (7): 1237–1242.

  • Liganded RARα upregulates the expression of GFI1.

  • GFI1 binds the Il9 gene and suppresses Th9 polarization.

ALLERGY AND OTHER HYPERSENSITIVITIES

J Immunol (2022) 209 (7): 1243–1251.

  • Active systemic anaphylaxis in mice shows Ag retention specifically in the lung.

  • Ag is predominantly captured by neutrophils and monocytes.

  • Neutrophils and monocytes activate locally in the lung during anaphylaxis.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2022) 209 (7): 1252–1259.

  • NAbs alert the immune system against nascent neoantigen-expressing cells.

  • NAbs are required to induce a CTL response against neoantigen-expressing cells.

  • NAb-tagged cells mount immunity against immunogenic and nonimmunogenic Ags.

AUTOIMMUNITY

J Immunol (2022) 209 (7): 1260–1271.

  • Human CBLB-KO CD4+ T cells are resistant to Treg suppression in vitro.

  • CBLB-KO cells overcome Treg suppression on transcriptional and translational levels.

J Immunol (2022) 209 (7): 1272–1285.

  • Brain CD8+ T cells of aged WT and APP-PS1 mice are identified as Trm T cells.

  • Upregulated genes of brain CD8+ cells are involved in type I IFN signaling.

IMMUNE REGULATION

J Immunol (2022) 209 (7): 1286–1299.

  • RNA-seq profiling delineates cDC1 responses to extracellular stimuli.

  • Poly(I:C) activates autocrine IFN-I signaling in cDC1s.

  • IL-10 inhibits autocrine IFN-I responses in cDC1s via STAT3.

IMMUNE SYSTEM DEVELOPMENT

J Immunol (2022) 209 (7): 1300–1313.

  • Tregs develop via distinct agonist and postagonist stages.

  • CD25+ TregP agonist cells are a main source of IL2 needed for Treg development.

  • Thymic recirculating Tregs have highly diverse transcriptomes and TCRs.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2022) 209 (7): 1314–1322.

  • Coronavirus impairs host immunity against secondary bacterial infections.

  • Coronavirus-induced lysosomal dysfunction impairs bacterial killing.

  • Targeting lysosomal enzyme cathepsin B limits pyroptotic cell death.

J Immunol (2022) 209 (7): 1323–1334.

  • Obesity reduced susceptibility to pulmonary bacterial infection.

  • Obesity resulted in a dysregulated lung lipidome and lipid response to infection.

  • Rapid production of COX-2 products was essential for survival of lung infection.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2022) 209 (7): 1335–1347.

  • FTRCA1 is a fish-specific E3 ligase with RNA-binding activity.

  • FTRCA1 impairs STING1 and IRF7 mRNA levels to downregulate the IFN response.

  • FTRCA1 targets TBK1 protein degradation to downregulate the IFN response.

J Immunol (2022) 209 (7): 1348–1358.

  • Myeloid MCPIP1 controls the endotoxin tolerance.

  • MCPIP1 ensures the tolerance to LPS via restriction of the NF-κB signaling pathway.

  • MCPIP1 determines endotoxin tolerance independently of its RNase activity.

J Immunol (2022) 209 (7): 1359–1369.

  • Crosslinking of HLA I triggers complex formation between TLR4 and HLA I in ECs.

  • P-selectin externalization and monocyte binding induced by HLA I Ab depend on TLR4.

  • TLR4 functions as a coreceptor of HLA I in human ECs.

J Immunol (2022) 209 (7): 1370–1378.

  • Ligature-induced periodontitis activates complement in a microbiota-dependent manner.

  • Complement C3 deficiency inhibits LIP-induced IL-6 and IL-23 and Th17 expansion.

  • Complement links the periodontal microbiota to Th17 expansion and bone loss.

SYSTEMS IMMUNOLOGY

J Immunol (2022) 209 (7): 1379–1388.

  • Unique cell subpopulations predominant in atopic dermatitis samples were identified.

  • Putative biomarkers associated with disease progression were found.

TRANSPLANTATION

J Immunol (2022) 209 (7): 1389–1400.

  • A decrease in effector memory donor-reactive CD4 T cells after transplantation was shown.

  • A decrease in polyfunctional (producing ≥2 cytokines) donor-reactive CD4 T cells was also seen.

  • Increased apoptosis in donor-reactive CD4 T cells after transplantation is also demonstrated.

TUMOR IMMUNOLOGY

J Immunol (2022) 209 (7): 1401–1413.

  • Lnc57Rik can be induced by tumor-associated factors.

  • Lnc57Rik promotes the immunosuppressive function of MDSCs.

  • Lnc57Rik binds with the C/EBPβ isoform LAP and WDR5.

CORRECTIONS

J Immunol (2022) 209 (7): 1414.
J Immunol (2022) 209 (7): 1415.
Close Modal

or Create an Account

Close Modal
Close Modal